Abstract

The activity of AMPA-type glutamate receptor is involved in insulin release from pancreatic β-cells. However, the mechanism and dynamics that underlie AMPA receptor-mediated insulin release in β-cells is largely unknown. Here, we show that AMPA induces internalization of glutamate receptor 2/3 (GluR2/3), AMPA receptor subtype, in the mouse β-cell line MIN6. Immunofluorescence experiments showed that GluR2/3 appeared as fine dots that were distributed throughout MIN6 cells. Intracellular GluR2/3 co-localized with AP2 and clathrin, markers for clathrin-coated pits and vesicles. Immunoelectron microscopy revealed that GluR2/3 was also localized at plasma membrane. Surface biotinylation and immunofluorescence measurements showed that addition of AMPA caused an approximate 1.8-fold increase in GluR2/3 internalization under low-glucose conditions. Furthermore, internalized GluR2 largely co-localized with EEA1, an early endosome marker. In addition, GluR2/3 co-immunoprecipitated with cortactin, a F-actin binding protein. Depletion of cortactin by RNAi in MIN6 cells altered the intracellular distribution of GluR2/3, suggesting that cortactin is involved in internalization of GluR2/3 in MIN6 cells. Taken together, our results suggest that pancreatic β-cells adjust the amount of AMPA-type GluR2/3 on the cell surface to regulate the receptive capability of the cell for glutamate.Key words: endocytosis, GluR2, AMPA, cortactin, MIN6.

Highlights

  • Receptor subtype, in the mouse β-cell line MIN6

  • Cortactin is involved in the maintenance of intracellular localization of amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor in MIN6 cells observed throughout cells (Fig. 1C)

  • Cles were often found on the cytoplasmic surface of the plasma membrane and the internal vacuolar membrane (Fig. 2). These results suggest that glutamate receptor 2/3 (GluR2/3) are, at least in part, internalized in MIN6 cells

Read more

Summary

Materials and Methods

A rabbit polyclonal antibody recognizing the cytoplasmic domain (KQNFATYKEGYNVYGIESVKI) of GluR2/3 (cat# 07-598), a mouse monoclonal antibody recognizing amino acid residues. MIN6 cells were fixed with 4% paraformaldehyde and stained for immunofluorescence as described previously (Yamada et al., 2013). Were incubated with 2.5 mg of mouse brain extract in lysis buffer with a protease inhibitor cocktail at 4°C for 1 h. After washing with PBS (+), cells were incubated in low-glucose Ringer’s solution with or without 0.5 mM AMPA (cat#A9111, Merck KGaA) for 15 min at 37°C. Cells were washed with ice-cold low-glucose Ringer’s solution five times to remove excessive antibody. 0.1 M PB containing 0.1 M glycine and 1% bovine serum albumin (BSA), blocked with 1% BSA in 0.1 M PB for 10 min, and incubated with an anti-intracellular GluR2 antibody Whole mouse brain or MIN6 cells were homogenized in PBS containing a protease inhibitor cocktail (Roche Diagnostics) with a Potter-type glass-Teflon homogenizer. The membrane was blocked with 140 mM NaCl, 1 mM EDTA, 20 mM Tris-HCl

Results
Discussion
Availability of data and materials
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call